Eptifibatide-Induced Severe Thrombocytopenia After ST-Elevation Myocardial Infarction (STEMI): A Case Report

Eptifibatide is a platelet glycoprotein (GP) IIb/IIIa inhibitor that is used in certain cases of acute coronary syndrome, including those with high thrombus burden or with no-reflow. It can rarely be associated with severe thrombocytopenia, which brings up a dilemma in managing those patients who re...

Descripción completa

Detalles Bibliográficos
Autores principales: Gheith, Zaid, Kilani, Areej, Nguyen, Tam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594682/
https://www.ncbi.nlm.nih.gov/pubmed/36312599
http://dx.doi.org/10.7759/cureus.29549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594682/
https://www.ncbi.nlm.nih.gov/pubmed/36312599
http://dx.doi.org/10.7759/cureus.29549

Ejemplares similares